Latest Market Distributions News

Page 1 of 2
Argent BioPharma has granted Thai Phytomed International exclusive global commercialisation rights to four cannabis genotypes under a 10-year agreement. The deal preserves Argent’s ownership, but royalties depend on TPI generating profitable sales and securing approvals across multiple markets.
Victor Sage
Victor Sage
27 Oct 2026
Memphasys has reported record September-quarter invoiced revenue of A$211,000 as its Felix fertility device moves into more international markets. The commercial progress comes alongside A$3.5 million in funding, but the loan still requires shareholder approval for conversion into notes.
Ada Torres
Ada Torres
13 Oct 2026
CurveBeam AI’s FY2026 results show a 28% revenue decline and a 12% increase in net loss, while advancing its China commercialisation and robotic surgery integration strategies. The company also announced a $6-7 million capital raise post-year-end.
Ada Torres
Ada Torres
31 Aug 2026
Scott Technology aims to more than double Protein Domain revenue to NZ$165 million by FY30, leveraging global growth of its BladeStop safety bandsaw and a new Mexico distribution deal.
Victor Sage
Victor Sage
26 Aug 2026
icetana AI has expanded its strategic partnership with SoftBank Robotics Group by signing a distribution agreement with SoftBank Robotics America, marking its entry into one of the world's largest security technology markets.
Sophie Babbage
Sophie Babbage
12 June 2026
EVE Health Group has completed manufacturing and distribution setup for Libbo™, its innovative oral dissolving film for erectile dysfunction, paving the way for near-term patient access via telehealth and pharmacy channels.
Ada Torres
Ada Torres
30 Jan 2026
Banco Santander has launched a A$450 million tranche of floating rate senior notes due in 2031, targeting exclusively professional and eligible counterparties under MiFID II regulations. The notes offer a quarterly interest rate tied to the 3-month BBSW plus a margin of 0.97%.
Claire Turing
Claire Turing
16 Jan 2026
CurveBeam AI has received official Chinese regulatory approval for a strategic $10 million investment from WEGO Orthopaedics, marking a major step in its expansion into Greater China. The initial $4 million tranche at a premium share price is expected imminently, underpinning a decade-long commercialisation deal.
Ada Torres
Ada Torres
7 Jan 2026
Vanguard Investments Australia has announced final distribution amounts and key dates for 27 of its ETFs, with payments scheduled for mid-January 2026. Investors can also participate in the Distribution Reinvestment Plan across all funds.
Claire Turing
Claire Turing
5 Jan 2026
Zeotech Limited has signed a non-binding Letter of Intent with Bisley & Company to explore marketing and distribution of its high-reactivity metakaolin product, AusPozz™, across Australia and key international markets.
Maxwell Dee
Maxwell Dee
18 Nov 2025
Australian Dairy Nutritionals reported a 66% year-on-year revenue increase in Q1 FY26, driven by strong nutritional powder sales and expanded distribution in China, while improving cash flow and production capacity.
Victor Sage
Victor Sage
30 Oct 2025
CurveBeam AI has inked a decade-long exclusive partnership with a major Chinese medical device joint venture, unlocking rapid market entry and a $10 million capital boost to expand its weight bearing CT and AI solutions across Greater China.
Ada Torres
Ada Torres
30 Oct 2025

Browse the archive

Full archive